Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Desidustat in COVID-19
NCT04463602Phase 2Completed
- Sponsor
- Zydus Lifesciences Limited
- Start
- Jul 2020
- Primary completion
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of desidustat in coronavirus disease 2019 (COVID-19), sponsored by Zydus Lifesciences Limited. Started Jul 2020; status: completed.
02
Drugs
desidustat
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04463602.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04463602.